MED Stock Overview
MEDICLIN Aktiengesellschaft operates hospitals in Germany.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
MEDICLIN Aktiengesellschaft Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €3.00 |
| 52 Week High | €3.82 |
| 52 Week Low | €2.90 |
| Beta | 0.13 |
| 1 Month Change | 0% |
| 3 Month Change | -7.98% |
| 1 Year Change | -15.25% |
| 3 Year Change | -22.68% |
| 5 Year Change | -51.61% |
| Change since IPO | -72.85% |
Recent News & Updates
Shareholder Returns
| MED | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | 2.3% | 1.4% |
| 1Y | -15.3% | -19.3% | -7.2% |
Return vs Industry: MED exceeded the German Healthcare industry which returned -20.3% over the past year.
Return vs Market: MED underperformed the German Market which returned -7.9% over the past year.
Price Volatility
| MED volatility | |
|---|---|
| MED Average Weekly Movement | 3.6% |
| Healthcare Industry Average Movement | 4.3% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.7% |
Stable Share Price: MED is less volatile than 75% of German stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: MED's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 7,061 | Joachim Ramming | https://www.mediclin.de |
MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute, Acute, and Other Activities segments. It offers medical services in the areas of neurology, psychosomatics, orthopedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, surgery, nursing care, and others.
MEDICLIN Aktiengesellschaft Fundamentals Summary
| MED fundamental statistics | |
|---|---|
| Market Cap | €142.50m |
| Earnings (TTM) | €7.03m |
| Revenue (TTM) | €723.14m |
20.3x
P/E Ratio0.2x
P/S RatioIs MED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MED income statement (TTM) | |
|---|---|
| Revenue | €723.14m |
| Cost of Revenue | €594.86m |
| Gross Profit | €128.28m |
| Other Expenses | €121.25m |
| Earnings | €7.03m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Jul 31, 2023
| Earnings per share (EPS) | 0.15 |
| Gross Margin | 17.74% |
| Net Profit Margin | 0.97% |
| Debt/Equity Ratio | 46.7% |
How did MED perform over the long term?
See historical performance and comparison